Fundamental Analysis
31 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -31.6% | -85.4% | 0 / 3 | +95.6% | -2.71 pp | -0.90 pp | +3.2% | 1.24 | 18.45 | 79,8 | +95,6% | 1,7 | +36,8% | 18.45 | 23.01 | −19,8% |
| Pts | 0 | 0 | 0 | 12 | 4 | 4 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 8.900 (close price on 2026-10-19)EPS (TTM): 482,3
Financial charts
1.Revenue & growth
VND bn79,8Q2/26
1.Revenue & growth
VND bn79,8Q2/26
2.Profit & growth
VND bn1,67Q2/26
3.Profit mix (Penman)
VND bn2,88Q2/26
4.Margins & cost structure
%6.5%Q2/26
5.Returns & cash cycle
% · days4.5%Q2/26
6.Earnings quality & cash
VND bn-10,5Q2/26
7.Asset structure
VND bn218Q2/26
8.Funding & debt health
VND bn · times218Q2/26
9.Revenue backlog
VND bn0,35Q2/26
10.Valuation
times · %26,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %269Q2/26
Adjusted EPS growth, latest quarter
-32.2%
Average adjusted EPS growth, 3 quarters
-85.6%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
100%
Source: vnstockData through Q2/26